Back to Bank of New York Mellon Corp Bank of New York Mellon Corp

LTRNLTRN
Showing 8 of 22 quarters

Position history for Bank of New York Mellon CorpBank of New York Mellon Corp's holdings in LANTERN PHARMA INC

Bank of New York Mellon Corp holds 21,301 shares of LTRN (LANTERN PHARMA INC), worth $88,825 as of 2026-Q2.

Current Value

$88,825

Current Shares

21,301

Total Value Change

-$8,365

Total Shares Change

-5,181

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
21,301
0.0%
$88,8250.0%$4.17
0
2026-Q1
Decreased
21,301
-19.6%
$29,1820.0%$2.71
0
2025-Q4
Unchanged
26,481
0.0%
$80,2370.0%$3.06
0
2025-Q3
Decreased
26,481
0.0%
$115,1930.0%$4.54
0
2025-Q2
Unchanged
26,482
0.0%
$83,6830.0%$3.19
0
2025-Q1
Unchanged
26,482
0.0%
$93,7460.0%$3.55
0
2024-Q4
Unchanged
26,482
0.0%
$84,4780.0%$3.27
0
2024-Q3
Unchanged
26,482
0.0%
$97,1900.0%$3.78
0

Other major holders of LTRN: NewEdge Advisors, LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used